Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.44 is 43% above its 1-year average of 1.00, near the high end of its 1-year range (0.00–1.44).
As of the fiscal period ended Tuesday, June 30, 2026. 14.27% above its 12-month average of 1.26.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.44.
QUICK RATIO (ACID-TEST)
1.44
QUICK RATIO (ACID-TEST) AVG TTM
1.26
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+14.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.23
median of 788 covered companies
CURRENT VS SECTOR MEDIAN
-55.42%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.03B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.26
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.12
3Y Avg
6.56
5Y Avg
10.14
Market Cap
$1.03B
Quick Ratio (Acid-Test)
16.35
TTM Avg
49.13
3Y Avg
36.31
5Y Avg
29.96
Market Cap
$1.04B
Quick Ratio (Acid-Test)
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$1.04B
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.08
3Y Avg
1.74
5Y Avg
1.96
Market Cap
$1.00B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.05B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$991.81M
Quick Ratio (Acid-Test)
5.35
TTM Avg
6.89
3Y Avg
6.87
5Y Avg
8.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.03B | 1.44 | 1.26 | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.03B | 7.54 | 10.49 | 6.85 | 5.34 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | 5.85 | 6.12 | 6.56 | 10.14 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | 16.35 | 49.13 | 36.31 | 29.96 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.04B | 8.42 | 11.89 | 15.48 | 17.00 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 1.98 | 1.08 | 1.74 | 1.96 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 0.81 | 2.16 | 2.71 | 2.89 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $991.81M | 5.35 | 6.89 | 6.87 | 8.97 |
| Pacira BioSciences, Inc. (PCRX)vs › | $982.98M | 3.94 | 2.64 | 3.04 | 2.66 |
Quick Ratio
1.44
Excludes inventory
Current Ratio
1.44
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.44 |
| 2026-03-31 | 1.40 |
| 2025-12-31 | 1.27 |
| 2025-09-30 | 0.92 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.99 |
